CN109536404A - A kind of feeding bacillus pumilus and its application - Google Patents

A kind of feeding bacillus pumilus and its application Download PDF

Info

Publication number
CN109536404A
CN109536404A CN201811453413.XA CN201811453413A CN109536404A CN 109536404 A CN109536404 A CN 109536404A CN 201811453413 A CN201811453413 A CN 201811453413A CN 109536404 A CN109536404 A CN 109536404A
Authority
CN
China
Prior art keywords
bacillus pumilus
bacillus
pumilus
group
feed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811453413.XA
Other languages
Chinese (zh)
Other versions
CN109536404B (en
Inventor
马曦
孙美鸽
姬琳堡
聂存喜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Agricultural University
Original Assignee
China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Agricultural University filed Critical China Agricultural University
Priority to CN201811453413.XA priority Critical patent/CN109536404B/en
Publication of CN109536404A publication Critical patent/CN109536404A/en
Application granted granted Critical
Publication of CN109536404B publication Critical patent/CN109536404B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification
    • A23L5/28Removal of unwanted matter, e.g. deodorisation or detoxification using microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of feeding bacillus pumilus (Bacillus pumilus) 13824, deposit number is CGMCC NO.16539.Bacillus pumilus 13824 of the invention is G+ bacteria, simultaneously resistance to 80 DEG C of high temperature, can be grown in the acidic environment of 2.0 or more pH value, bile tolerance ability is strong, has the function of mould mycin of degrading simultaneously, bacillus pumilus 13824 is made after microbial inoculum to be used for feeding animals effect safe and reliable, is promoting nutrient digestion to absorb, is reducing diarrhea rate, feed efficiency is improved, growth aspect is promoted to have positive effect.

Description

A kind of feeding bacillus pumilus and its application
Technical field
The invention belongs to microbiologies and feeding field of probiotic bacteria, specifically, being related to a kind of with bacteriostasis, resistance to height Warm, acidproof, bile tolerance feeding bacillus pumilus and its application.
Background technique
Currently, food-safety problem is just causing more and more to pay close attention to.In many reasons for causing food-safety problem, Important reason first is that using antibiotic as growth accelerator in feed.For normal bacteriosis, antibiotic is still It is primary treatment means;But in terms of promoting growth of animal, then other green additives is needed to gradually replace antibiotic Effect.So screening can effectively inhibit the pathogenic microorganisms such as Escherichia coli, salmonella, and animal productiong can be improved simultaneously The bacillus of energy, and the microecological bacillus preparation with the application stability such as feed processing, storage and transportation is developed, have scientific With the double meaning of reality.
The Tiny ecosystem industry development of China starts from last century late nineteen eighties, and very fast growth, mesh were entered at 2000 or so It is preceding, the white-hot stage of market development and product competition is progressed into, there are more and more enterprises both at home and abroad to start to set foot in this Field.And it is also anxious wait hasten one's steps in the technological development in probiotics field.Feeding microecological bacillus preparation product exists Feed bio-additive is much in the market, but the good and bad jumbled together;The strain prominent function and apparent product of application effect is less See.
Tiny ecosystem product presently, there are the problem of have: 1) stability of certain lactic acid bacteria class probiotic products is still under room temperature One insoluble problem, this causes the viable bacteria stability of product in shelf life not good enough;2) it takes rear probiotics and reaches intestines The viable count in road is influenced by the degeneration-resistant property of gastric acid, intestinal juice and strain itself, and difference is very big between different strain;3) bacillus It is proliferated efficiency etc. the sprouting of bacterium in animal body of passing by one's way, always exists dispute;4) physiological activity of probiotics has bacterial strain special Property, up to now, bacterial strain only few in number is proved to have more apparent physiological activity, and these prebiotic spies Property cannot exist simultaneously in same bacterial strain.In addition, although Tiny ecosystem has the row of the individual plants such as bacillus subtilis at present Industry standard occurs, but lacks unified industry quality standard there are also many probiotics preparations, and different Tiny ecosystem enterprises exists in addition There are bigger differences in terms of strain exploitation and management, production technology and quality control, product design and application scheme, so micro- life State industry generally need further to standardize.
The research for obtaining the novel bacillus with probiotic properties is of great significance.Separation and screening anti-microbial pathogen and Bacillus pumilus with probiotic effects can preferably be applied to feed addictive, to replace antibiotic.But short and small gemma Bacillus is less as the research and application of probiotics preparation or feed addictive, especially in substitution feeding antibiotic and reduction ring Border pollution etc..
Summary of the invention
The object of the present invention is to provide one kind have bacteriostasis, high temperature resistant, acidproof, bile tolerance and have degradation mould poison The feeding bacillus pumilus of element effect and its application.
In order to achieve the object of the present invention, bacillus pumilus of the invention (Bacillus pumilus) is from Beijing It screens in soil near certain pig raising Experimental Base and is obtained by ultraviolet light mutagenesis, be named as 13824.Through 16S rna gene sequence Column analysis, the bacterial strain 13824 are bacillus pumilus (Bacillus pumilus).The bacterial strain was protected on September 27th, 2018 Ensconce China Committee for Culture Collection of Microorganisms's common micro-organisms center (abbreviation CGMCC, address: Chaoyang District, Beijing City north The institute 3 of occasion West Road 1, Institute of Microorganism, Academia Sinica, postcode 100101), classification naming is bacillus pumilus (Bacillus pumilus), deposit number are CGMCC No.16539.
The Microbiological Characteristics of bacillus pumilus (Bacillus pumilus) 13824 are as follows: gram-positive bacteria, cell Form be it is rod-shaped, of length no more than 3 μm, width is no more than 0.7 μm, and there is gemma and gemma not expand;Single colonie size is 10- 12mm, color are in faint yellow, opaque, bacterium colony surface folding, and edge is irregular.Thallus survival rate after 80 DEG C of processing 10min Up to survival rate after 95% or more, 20min still up to 90% or more, can be grown in the acidic environment of 2.0 or more pH value, bile tolerance energy Power is strong.And there is the ability of certain degradation mycotoxin, 9.75% is reached to the degradation rate of fumonisin, to vomitoxin Degradation rate reach 7.33%.
The present invention provides the microbial inoculum containing the bacillus pumilus 13824.
The present invention also provides a kind of animal feed additives containing the bacillus pumilus 13824.The feed addictive 13824 viable count of bacillus pumilus contained is 1 × 108CFU/g~1 × 1012CFU/g;Preferably, the short and small gemma contained The viable count of 13824 feed addictive of bacillus is 1 × 109CFU/g~1 × 1011CFU/g。
The present invention also provides a kind of animal feeds containing the bacillus pumilus 13824.Wherein, in the animal feed The viable count of bacillus pumilus 13824 is 1 × 106CFU/kg~1 × 109CFU/kg, preferably 1 × 107CFU/kg~1 × 108CFU/kg。
The present invention identifies the probiotic effects of bacillus pumilus 13824 by vitro method, the results showed that, short and small gemma bar Bacterium 13824 can acidproof, sour cholate, the interior environment of gastrointestinal tract can be resisted, have the potentiality of probiotics.
It has also been found that ability of the bacillus pumilus 13824 with degradation mycotoxin, therefore the present invention provides The drug of inhibition mycotoxin containing bacillus pumilus 13824, and provide bacillus pumilus 13824 and eaten in reduction Application in product or Mycotoxins in Feed pollution.In the embodiment of the present invention, 13824 pairs of volt horse poison of bacillus pumilus are demonstrated The degradation rate of element reaches 9.75%, reaches 7.33% to the degradation rate of vomitoxin.Those skilled in the art being capable of gene this hair The bacillus pumilus 13824 of bright offer, for verifying its degradation effect to other mycotoxins, this is without departing from this field skill The basic capacity range of art personnel, therefore bacillus pumilus 13824 has degradation mycotoxin and is used to prepare degradation mould The drug of toxin and the application in reduction food or Mycotoxins in Feed pollution all belong to the scope of protection of the present invention.
Feeding bacillus pumilus of the present invention, since gemma structure is bad to drying, high temperature, high pressure, oxidation etc. Environmental resistance is very strong, and this stability increases its potentiality as probiotics.The present invention further demonstrates short and small gemma Application effect of the bacillus 13824 in weanling pig feed addition, it is found that the bacterial strain has reduces the raising of diarrhea of weaned piglets rate The effect of feed conversion rate.Show that bacillus pumilus 13824 can be used as a kind of novel probiotic additive, is widely used in In feed.The bacillus pumilus 13824 that the present invention screens, which has, improves efficiency of feed utilization, promotes nutriment in feed Digestion and absorption;Enhance the immune function of animal, improve daily gain, reduces feedstuff-meat ratio;It is pollution-free, noresidue, biological environmental production etc. Feature has significant effect in terms of promoting growth of animal and improving the weight of animals.
Detailed description of the invention
Fig. 1 is the colonial morphology figure of bacillus pumilus (Bacillus pumilus) 13824CGMCC No.16539.
Fig. 2 is the Gram's staining figure of bacillus pumilus (Bacillus pumilus) 13824CGMCC No.16539.
The acid resistance that Fig. 3 is bacillus pumilus (Bacillus pumilus) 13824CGMCC No.16539 detects knot Fruit.
The bile tolerance that Fig. 4 is bacillus pumilus (Bacillus pumilus) 13824CGMCC No.16539 detects knot Fruit.
Fig. 5 is the growth curve of bacillus pumilus (Bacillus pumilus) 13824CGMCC No.16539.
Fig. 6 is to carry out mouse filling using bacillus pumilus (Bacillus pumilus) 13824CGMCC No.16539 Stomach excess test after Histological Study figure.
Specific embodiment
The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention..Unless otherwise specified, embodiment Used in the conventional means that are well known to those skilled in the art of technological means.Material as used in the following examples, examination Agent etc. is commercially available unless otherwise specified.
Culture medium as used in the following examples is formulated as follows unless otherwise specified: LB culture medium: tryptone 10g, Yeast extract 5g, sodium chloride 10g are settled to 1L with distilled water, and pH is adjusted to 7.0 with the sodium hydroxide of 5mol/L.
The separation and identification of 1 bacillus pumilus of embodiment (Bacillus pumilus) 13824
One, the separation of bacterial strain 13824
1. bacterial strain is separately cultured
The pedotheque near the Haidian District, Beijing City 1g China Agricultural University western school district pig raising base is taken to be incorporated with 9ml physiology In the test tube of salt water, vortex device concussion is mixed, as 1:10 dilution, then is taken dilution to carry out 10 times and be incremented by dilution, is then selected Each 1ml of dilution for selecting 3 suitable gradients is coated on LB culture medium.37 DEG C culture 48-72 hours, observe and record bacterium colony shape State, the single colonie that picking grows fine carry out scribing line and isolate and purify.
2. ultraviolet mutagenesis and the screening of bacterial strain
LB culture medium after sterilizing is poured into culture dish, the resulting bacteria suspension of step 1 is taken to be coated on plate after to be solidified On, each culture dish control bacterium colony is at 50 or so, after culture 12 hours, apart from ultraviolet lamp 20cm, mutagenesis 30s.
Bacterial strain after picking mutagenesis, is inoculated in LB liquid medium, cultivates 24 hours, measures OD value, chooses growth speed Faster bacterial strain is spent, suitable bacteria suspension is taken to be coated on LB plate, culture was carried out to 24 hours in 37 DEG C of constant incubators Next step Gram's staining.
3. the Gram's staining of bacterial strain
Sterilized distilled water is dripped on glass slide, the faster single colonie (bacterium of the speed of growth after one mutagenesis of picking Fall aspect graph and see Fig. 1) it dissolves in water, after scraping blade, dries and fix on alcolhol burner.Violet staining liquid is added dropwise, contaminates 2min, Washing, naturally dry;Iodine solution mordant dyeing 2min, washing, naturally dry is added dropwise;Basic fuchsin ethanol solution 50S is added dropwise, washes, from So dry;It is observed on ordinary optical microscope, if thallus is purple for the positive, thallus takes on a red color as feminine gender, as a result sees Fig. 2. It chooses Gram-positive bacillus and carries out next step spore staining experiment.
4. the spore staining of bacterial strain
The faster bacterial strain of the speed of growth after step 2 of learning from else's experience mutagenesis, drips sterilized distilled water, picking on glass slide One single colonie dissolves in water, after scraping blade, dries and fixes on alcolhol burner.5% malachite green solution 3-5 drop is added dropwise, 3-5min is heated on alcolhol burner, pays attention to that liquid boiling or withered, washing, naturally dry cannot be made;The dyeing of Huang red solution is added dropwise 2min, washing, naturally dry;It is observed under ordinary optical microscope, gemma takes on a red color in green, thallus.
By the separation screening of step 1-4, one plant of Gram-positive is finally obtained, there is gemma and gemma does not expand Bacterial strain.It is 13824 by the strain number.
Two, the identification of bacterial strain 13824
1. Morphological Identification
To in logarithmic growth phase and the stable bacterial strain 13824 of bacterium colony size carries out single colonie state description, mainly include Size, color, transparency, bacterium colony surface state and the colony edge state of bacterium colony.Gained single colonie size is 10-12mm, face Color is in faint yellow, opaque, bacterium colony surface folding, and edge is irregular.
Secondly the bacterial strain 13824 in logarithmic growth phase is dyed, using optical microphotograph sem observation thalli morphology.Point From and the bacterial strain 13824 that screens, Gram's staining is positive, cellular morphology be it is rod-shaped, diameter is no more than 1 μm, has gemma raw At and gemma do not expand.
2.16S RNA sequence homology analysis
The extraction of bacteria total DNA is extracted using the bacterial genomes DNA extraction kit of Tiangeng biochemical technology Co., Ltd. Sample after extraction is sent to Shanghai Major Biological Medical Technology Co., Ltd. and is sequenced.By measurement result in GenBank data BLAST sequence analysis is carried out in library, determines that strain classification is bacillus pumilus (Bacillus pumilus).
It is above-mentioned the experimental results showed that, the bacterium be bacillus pumilus.The bacterial strain was preserved in China on September 27th, 2018 Microbiological Culture Collection administration committee common micro-organisms center (abbreviation CGMCC, address: BeiChen West Road, Chaoyang District, BeiJing City 1 Institute 3, Institute of Microorganism, Academia Sinica, postcode 100101), classification naming is bacillus pumilus (Bacillus Pumilus), deposit number is CGMCC No.16539.
The resistance of 2 bacillus pumilus 13824 of embodiment detects
1. heat resistance detects
By (CGMCC No.16539) bacterium solution of bacillus pumilus 13824 as 20 minutes in water-bath, respectively with 60 DEG C, 80 DEG C, 100 DEG C of processing, 3 repetitions of each processing, after treatment measure its viable count using tilt-pour process.
Bacillus pumilus 13824CGMCC No.16539 is handled after twenty minutes at 60 DEG C, and survival rate is up to 99%, 80 DEG C Processing still can reach 80% or more up to 90% or more, 100 DEG C of processing after twenty minutes after twenty minutes.
2. acid resistance detects
Bacillus pumilus 13824 is inoculated into respectively in the LB culture medium that pH value is 2.0,3.0,4.0,5.0,6.0, point Its viable count is not measured using plate tilt-pour process in 1h, 2h, 3h, 4h.
When being 5.0 or 6.0 in weak acid environment, that is, pH, bacillus pumilus can be with normal growth, when pH is 4.0 When, slightly have inhibiting effect to the growth of bacillus pumilus, when pH be 2.0 or 3.0 when, have when viable count is compared with pH5.0 or 6.0 compared with Big decline, but still 1 × 10 can be maintained6CFU/ml.As a result see Fig. 3, when pH is 2, after inoculation viable bacteria 4 hours, viable bacteria It is consistent substantially when quantity is with inoculation.Illustrate that the strain is extremely strong to the tolerance of acid.As a result bacillus pumilus is prompted 13824 can be resistant to the influence of gastric acid.
3. bile tolerance detects
Activated bacillus pumilus 13824CGMCC No.16539 is done into doubling dilution with sterile saline, is selected It takes suitable dilution gradient and draws 1ml dilution and be put in sterile petri dish, do 6 repetitions, then use ox containing various concentration The LB culture medium pour plate of sodium taurocholate (0.1%, 0.2%, 0.3%, 0.4%), 37 DEG C were cultivated 4 hours, every 1 hour bacterium colony Count, at the same be free of natrii tauroglycocholas LB culture medium pour plate, 37 DEG C cultivate 48 hours, bacterium colony counting, as a control group, See Fig. 4, as the result is shown the viable count under different gallbladder salinities with the extension of time it is generally on a declining curve.0.1% cholate The influence acted on to bacillus pumilus 13824 is fainter, has little influence on its normal growth.In 0.2% and 0.3% gallbladder After salt action 4 hours, viable count is average still to may remain in 5lg cfu/ml, living behind cholate effect 4 hours of 0.4% Bacterium number average out to 4.7lg cfu/ml, bacillus pumilus 13824 more than half survive under 0.4% cholate, illustrate short The bile tolerance ability of bacillus pumilus 13824 is stronger.
4. antibiotics sensitivity detects
The bacillus pumilus 13824CGMCC No.16539 of suitable concentration is coated on LB culture medium, each culture 4 drug sensitive test papers are uniformly attached in ware, are cultivated 36 hours, and inhibition zone size is observed.
13824 pairs of 1 bacillus pumilus of table different antibiotics sensitivity results
Title Antibacterial circle diameter (mm) Susceptibility
Tetracycline 10-14 In it is quick
Streptomysin 15-20 Gao Min
Penicillin 15-20 Gao Min
Gentamicin >20 It is extremely quick
Erythromycin >21 It is extremely quick
Cefradine >22 It is extremely quick
Amoxicillin >23 It is extremely quick
Chloramphenicol >24 It is extremely quick
Florfenicol >25 It is extremely quick
This result shows that, bacillus pumilus 13824CGMCC No.16539 simultaneously do not have good drug resistance, therefore It is safe and reliable for using as feeding probiotics.
5. bacillus pumilus 13824 tests the degradation effect of mycotoxin
Bacillus pumilus is seeded in 2ml contains 40 μ g/ml vomitoxins and 2ml contains 40 μ g/ml volt horse poison respectively It in the fluid nutrient medium of element, is cultivated 3 days under control environment, expands concentration and carry out repeating test to 60 μ g/ml, using height after 3 days Effect liquid phase chromatogram method detects the concentration of vomitoxin and fumonisin in culture medium, different degrees of decline occurs, shows Bacillus pumilus 13824 has the ability of degradation mycotoxin.Its to the degradation rate of fumonisin up to 9.75%, to vomiting poison The degradation rate of element is up to 7.33%.The calculation of degradation rate is (mycotoxin additive amount-mycotoxin residual quantity)/mycotoxin Additive amount × 100%.
The growth curve of 3 bacillus pumilus 13824 of embodiment measures
Growth curve represents the bacterium dynamic of growth and breeding up to aging death overall process in new suitable environment Variation.The inoculum concentration that bacillus pumilus 13824CGMCC No.16539 is pressed to 10% (v/v), is inoculated into LB culture medium, 37 DEG C culture 46 hours, the LB culture medium of bacterium solution is not added as blank control, every 2-6 hours measurement OD600 values, to calculate Viable count.Experiment is set to be repeated three times, as a result takes its average value, is recorded data and is drawn growth curve.As shown in figure 5, in 0-22 Hour, bacillus pumilus 13824 is in logarithm growth stage, and proliferative speed is higher.In 22-46 hours bacillus pumilus 13824 numbers tend towards stability.Enter the growth rate decline stage after 46 hours.
The preparation of 4 Bacillus pumilus preparation of embodiment
1. fermentative medium formula: brown sugar 40g/L, dregs of beans 35g/L, sodium chloride 4g/L, potassium dihydrogen phosphate 0.8g/L, sulfuric acid Manganese 0.3g/L, magnesium sulfate 0.03g/L, defoaming agent 0.05% (v/v) plus water sufficiently dissolve, and control pH in the range of 6.6-6.9 Fermentation medium is made.
2.121 DEG C high-temperature steam sterilization 30min.
3. being inoculated with 24 hours bacterium solutions of cell age 5% (v/v) when fermentation medium is cooled to 30 DEG C.
4. keeping revolving speed 250rpm stirring under the conditions of 37 DEG C, fermented and cultured 20 hours, putting tank, obtain short and small gemma bar The viable count of bacterium is greater than 2.0 × 109Cfu/ml, gemma rate is up to 95% or more.
5. bacterium mud to be put into low-temperature vacuum drying case to dry, sieving, collection product obtains Bacillus pumilus preparation.
Safety evaluatio the present embodiment of 5 bacillus pumilus 13824CGMCC No.16539 preparation of embodiment is with mouse As experimental animal, the method tested using stomach-filling evaluates the safety of bacillus pumilus, the specific method is as follows:
1. the freeze-dried powder of bacillus pumilus microbial inoculum made from 4 method of embodiment, measures through plate count, short and small gemma 13824 bacterium number of bacillus is 1.9 × 109cfu/g。
2. choosing mouse 72 of 8 week old or so, being randomly divided into 4 groups, (A group is that control group gavages sterile saline, B group It is high dose group according to 1.9 × 109The amount of cfu/ only gavages bacterium solution, and C group is middle dose group according to 1 × 108The amount of cfu/ only gavages Bacterium solution, D group are low dose group according to 1 × 107The amount of cfu/ only gavages bacterium solution), every group of 3 repetitions, 6 mouse of each repetition.
3. every morning, 9 stomach-fillings were primary, continuously gavage 21 days.
Control temperature humidity in experimental mouse room is constant, natural lighting, and mouse is freely eaten, drinks water, every 7 days cleaning mouse cages one It is secondary.In experimentation, the state of mouse is observed and recorded daily, survival condition, whether there is or not clinical abnormal symptoms etc..
Testing index:
(1) terminate the same day by the way of heart extracting blood in experiment, experiment mice blood sample is obtained, after static centrifugation Serum is obtained, it is solid for detecting Human Serum Albumin, total protein, high-density lipoprotein, low-density lipoprotein, triglycerides, gallbladder The blood parameters such as alcohol, urea, tumor necrosis factor alpha.
(2) it takes the complete heart, liver,spleen,kidney (bilateral) to claim weight in wet base, calculates separately cardiac index=(wet heart weight/weight) × 100%, liver index=(liver wet weights/weight) × 100%, index and spleen index=(spleen weight in wet base/weight) × 100%, kidney Dirty index=(kidney weight in wet base/weight) × 100%.
(3) take the jejunum of each group experimental mouse, ileum, colon, liver, kidney, lung tissue solid in 4% paraformaldehyde It is fixed, be dehydrated, embed and etc. slice is made, by the variation of the method observation form of hematoxylin eosin stain, as a result see figure 6。
2 different disposal group mouse survival situation of table
A group B group C group D group
7 days Survival Survival Survival Survival
14 days Survival Survival Survival Survival
21 days Survival Survival Survival Survival
From table 2 it can be seen that using bacillus pumilus 13824CGMCC No.16539 to after intragastric administration on mice 21 days, it is real It tests each processing group mouse to survive, illustrates above-mentioned bacillus pumilus to animal safety.
The organ coefficient of 3 different disposal group mouse of table
A group B group C group D group
Heart 0.62 0.61 0.63 0.65
Liver 5.52 5.58 5.57 5.49
Spleen 0.41 0.41 0.42 0.44
Kidney 1.34 1.32 1.35 1.37
From table 3 it can be seen that the organ index of processing group mouse illustrates above-mentioned short compared with the control group without significant change Bacillus pumilus does not cause Organs of Mice abnormal.
Using Biochemical Analyzer detection mice serum in albumin, total protein, high-density lipoprotein, low-density lipoprotein, Triglycerides, cholesterol, urea, tumor necrosis factor alpha etc., as a result display is normal, illustrates that the embodiment of the present invention 4 provides Bacillus pumilus preparation influence is not constituted on the physical signs of mouse.
The application of 6 bacillus pumilus 13824CGMCC No.16539 preparation of embodiment
28 age in days Ternary Pig three way cross weanling pig 72 is chosen in this experiment, experiment periods 45 days, sets according to random district's groups Score is 2 groups, every group of 6 repetitions, 6 pigs of each repetition.A group is control group (basal diet group), and B group is processing group (base Bacillus pumilus preparation made from the embodiment 4 of 240g/t is added in plinth daily ration, living bacteria count is 2.0 × 109cfu/g)。
In totally enclosed type conservation pigsty, temperature is controlled at 25-27 DEG C feeding piglet during test, is freely eaten, drinking-water. Any antibiotic is free of in basal diet, piglet immunological is carried out according to routine immunization program.
Testing index: the production performance of each processing group weanling pig specifically includes following index:
1. the feed intake of record piglet daily, calculates average daily gain after the test;
2. recording pig weight on the day of on-test and end, average daily gain is calculated;
3. calculating feedstuff-meat ratio by the test result of a, b, calculation is average daily gain/average daily gain.
4. every morning, 10:00 observed and recorded the faecal condition of piglet during test, diarrhea of weaned piglets rate, abdomen are calculated Rush down rate (%)=(diarrhea head number × Diarrhoea days)/(pig number × test number of days) × 100%.
Influence of the Bacillus pumilus preparation to Production Performance of Weaning Pigs and diarrhea rate is added in 4 basal diet of table
Average daily gain (kg) Average daily gain (kg) Feedstuff-meat ratio Diarrhea rate (%)
A group 0.489 0.342 1.430 2.1
B group 0.482 0.367 1.313 0.9
From table 4, it can be seen that processing group piglet average daily gain and average daily gain be all significantly higher than control group (P < 0.05), feedstuff-meat ratio is substantially less than control group (P < 0.05), illustrates that the feed efficiency for adding Bacillus pumilus preparation is more preferable.It raises The grice diarrhoea rate that Bacillus pumilus preparation is added in material significantly reduces (P < 0.05), and illustrating that microbial inoculum of the invention has reduces The effect of diarrhea of weaned piglets rate.
Although above having used general explanation, specific embodiment and test, the present invention is made to retouch in detail It states, but on the basis of the present invention, it can be modified or is improved, this is apparent to those skilled in the art 's.Therefore, these modifications or improvements without departing from theon the basis of the spirit of the present invention, belong to claimed Range.

Claims (10)

1. bacillus pumilus (Bacillus pumilus) 13824, deposit number is CGMCC NO.16539.
2. containing the microbial inoculum of bacillus pumilus described in claim 1 (Bacillus pumilus) 13824.
3. the feed addictive containing bacillus pumilus described in claim 1 (Bacillus pumilus) 13824 is dynamic Object feed.
4. containing the drug of bacillus pumilus described in claim 1 (Bacillus pumilus) 13824.
5. drug as claimed in claim 4, which is characterized in that it is the drug for inhibiting mycotoxin.
6. drug as claimed in claim 5, it is characterised in that the mycotoxin is fumonisin, vomitoxin.
7. bacillus pumilus (Bacillus pumilus) 13824 described in claim 1 is mould in reducing food or feed Application in verticillium toxin pollution.
8. bacillus pumilus (Bacillus pumilus) 13824 described in claim 1 is in preparing feed addictive Using.
9. bacillus pumilus (Bacillus pumilus) 13824 described in claim 1 is in improving food conversion ratio Using.
10. bacillus pumilus (Bacillus pumilus) 13824 described in claim 1 is promoting growth of animal or raising Application in terms of the weight of animals.
CN201811453413.XA 2018-11-30 2018-11-30 Bacillus pumilus for feed and application thereof Active CN109536404B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811453413.XA CN109536404B (en) 2018-11-30 2018-11-30 Bacillus pumilus for feed and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811453413.XA CN109536404B (en) 2018-11-30 2018-11-30 Bacillus pumilus for feed and application thereof

Publications (2)

Publication Number Publication Date
CN109536404A true CN109536404A (en) 2019-03-29
CN109536404B CN109536404B (en) 2021-05-04

Family

ID=65851521

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811453413.XA Active CN109536404B (en) 2018-11-30 2018-11-30 Bacillus pumilus for feed and application thereof

Country Status (1)

Country Link
CN (1) CN109536404B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111548965A (en) * 2020-05-20 2020-08-18 山东省农业科学院生物技术研究中心 Donkey-derived bacillus pumilus and application thereof in preparation of medicine for treating diarrhea of donkey colt

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103937701A (en) * 2014-03-07 2014-07-23 上海海洋大学 Bacillus pumilus shou002 and application thereof
CN104263683A (en) * 2014-09-15 2015-01-07 中国农业科学院饲料研究所 Bacillus pumilus 315 with probiotic effect and application thereof
CN104388337A (en) * 2014-10-27 2015-03-04 中国水产科学研究院黄海水产研究所 Bacillus pumilus bacterial strain application thereof
CN104726359A (en) * 2014-08-26 2015-06-24 汕头大学 Bacillus pumilus BP and application thereof
WO2015151009A1 (en) * 2014-03-31 2015-10-08 Lubrizol Advanced Materials, Inc. Ferment extract of a bacterial strain for the increase of adiponectin levels

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103937701A (en) * 2014-03-07 2014-07-23 上海海洋大学 Bacillus pumilus shou002 and application thereof
WO2015151009A1 (en) * 2014-03-31 2015-10-08 Lubrizol Advanced Materials, Inc. Ferment extract of a bacterial strain for the increase of adiponectin levels
CN104726359A (en) * 2014-08-26 2015-06-24 汕头大学 Bacillus pumilus BP and application thereof
CN104263683A (en) * 2014-09-15 2015-01-07 中国农业科学院饲料研究所 Bacillus pumilus 315 with probiotic effect and application thereof
CN104388337A (en) * 2014-10-27 2015-03-04 中国水产科学研究院黄海水产研究所 Bacillus pumilus bacterial strain application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EL- REFAI II A 等: "Improvement of the newly isolated Bacillus pumilus FH9 keratinolytic activity", 《PROCESS BIOCHEMITRY》 *
周欣 等: "紫外诱变选育木聚糖酶高产菌株及产酶条件初步研究", 《生物技术》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111548965A (en) * 2020-05-20 2020-08-18 山东省农业科学院生物技术研究中心 Donkey-derived bacillus pumilus and application thereof in preparation of medicine for treating diarrhea of donkey colt
CN111548965B (en) * 2020-05-20 2022-03-18 山东省农业科学院 Donkey-derived bacillus pumilus and application thereof in preparation of medicine for treating diarrhea of donkey colt

Also Published As

Publication number Publication date
CN109536404B (en) 2021-05-04

Similar Documents

Publication Publication Date Title
CN106479924B (en) The preparation and application of a kind of clostridium butyricum and clostridium butyricum active bacteria preparation
CN110272842B (en) Lactobacillus plantarum LP104 with weight-losing and lipid-lowering functions
CN102876614B (en) Bacillus licheniformis and application of bacillus licheniformis
CN110218681A (en) One plant of lactobacillus fermenti KP101 and its application
CN110878266B (en) Lactobacillus johnsonii and application thereof
CN114806978B (en) Lactobacillus johnsonii SXDT-23 and application thereof
CN114574406B (en) Lactobacillus rhamnosus strain WKA55, and application and product thereof in preparation of product for preventing and treating alcoholic liver injury
CN101392223A (en) Breeding method of microbial feed additive strain
CN110079482B (en) Bacillus amyloliquefaciens for feed and application thereof
CN115322932B (en) Lactobacillus plantarum with anti-alcohol and sobering-up capabilities and application thereof
CN111304119B (en) Feeding bacillus subtilis for degrading fumonisins and application thereof
CN113088468B (en) Lactobacillus casei Ma. GLRGJ1 and application thereof
CN106479944B (en) A kind of bacillus amyloliquefaciens and its application
CN103013893A (en) Lactobacillus plantarum CCL67 and application of same
CN110452843A (en) A kind of feeding bacillus subtilis and its application
CN105341425A (en) Pig feed containing bacteriostatic microbial ecological agent and application thereof
WO2024055616A1 (en) Bacillus sp. strain and use thereof
CN106389478A (en) Applications of Bacteroides fragilis in treatment and/or prevention of obesity or diabetes mellitus
CN109536404A (en) A kind of feeding bacillus pumilus and its application
CN109609393A (en) The feeding abnormal Brunswick Durham yeast of one kind and its application
CN105274032B (en) A kind of antagonism campylobacter jejuni and the lactobacillus reuteri for inhibiting its flaA gene expression
CN105624071A (en) Lactobacillus salivarius XJP2 and application thereof
CN106387314A (en) Applications of Bacteroides fragilis in animal breeding
CN109161501A (en) A kind of feeding bacillus licheniformis and its application
CN105238727B (en) A kind of antagonism campylobacter jejuni and the lactobacillus plantarum for inhibiting its flaA gene expression

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant